Psoriasis outcome measures: A report from the GRAPPA 2012 annual meeting

Alice B. Gottlieb, April W. Armstrong

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


Psoriasis is a multisystem disease. The cutaneous and musculoskeletal manifestations (psoriatic arthritis) are well recognized. However, the other manifestations of psoriatic disease including metabolic syndrome, atherosclerotic cardiovascular disease, depression, poor self-esteem, and self-destructive habits including obesity, smoking and excess alcohol consumption are underappreciated. At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), members addressed the need to develop uniform, validated, standardized outcome measures for psoriatic disease, measures that are useful to all stakeholders including patients, physicians, regulators, and payers.

Original languageEnglish (US)
Pages (from-to)1428-1433
Number of pages6
JournalJournal of Rheumatology
Issue number8
StatePublished - Aug 2013


  • Comorbidities
  • National psoriasis foundation
  • Psoriasis
  • Psoriatic disease

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy


Dive into the research topics of 'Psoriasis outcome measures: A report from the GRAPPA 2012 annual meeting'. Together they form a unique fingerprint.

Cite this